Form 4: Clene Inc. Director Jacobovitz Shalom Reports Stock Option Grant
SEC Form 4
Director Jacobovitz Shalom reports the acquisition of stock options in Clene Inc.
Summary
- On February 27, 2025, Director Jacobovitz Shalom reported acquiring 4,293 stock options in Clene Inc.
- The options were granted under the Clene Inc. Amended 2020 Stock Plan.
- The exercise price is $4.42 per share, and the options vest immediately upon grant.
- The options expire on February 26, 2035.
Sentiment
Score: 6
Explanation: The sentiment is neutral as it reports a standard stock option grant to a director, which is a common practice.
Positives
- The immediate vesting of the options could incentivize the director to work towards the company's success.
Industry Context
Stock options are a common form of executive compensation in the biotechnology industry, aligning management's interests with those of shareholders.
Stakeholder Impact
- The stock option grant could potentially align the director's interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 02/27/2025 | Date of transaction: Stock options granted to Jacobovitz Shalom |
| 02/28/2025 | Date of report filing. |
| 02/26/2035 | Expiration date of the stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.